{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:21:26Z","timestamp":1785813686500,"version":"3.56.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,21]]},"DOI":"10.18632\/oncotarget.9427","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T18:39:39Z","timestamp":1465929579000},"page":"38210-38223","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy of CD46-targeting chimeric Ad5\/35 adenoviral gene therapy for colorectal cancers"],"prefix":"10.18632","volume":"7","author":[{"given":"Young-Suk","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manh-Hung","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Young","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjong","family":"Moon","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Chonnam National University, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwonseop","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chonnam National University, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keesook","family":"Lee","sequence":"additional","affiliation":[{"name":"Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Genitourinary Cancer Branch, Research Institute of National Cancer Center, Goyang, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Hemmi","sequence":"additional","affiliation":[{"name":"Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Eun","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Statistics, College of Natural Sciences, Chonnam National University, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaeyong","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Jemal","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"key":"2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","article-title":"Adenoviruses as gene-delivery vehicles","volume":"334","author":"Wilson","year":"1996","journal-title":"The New England journal of medicine"},{"key":"3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/bmj.321.7273.1397","article-title":"ABC of colorectal cancer: Innovative treatment for colon cancer","volume":"321","author":"Kerr","year":"2000","journal-title":"Bmj"},{"key":"4","first-page":"847","article-title":"Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression","volume":"63","author":"Curiel","year":"2003","journal-title":"Cancer research"},{"key":"5","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/v2102196","article-title":"Serotype chimeric human adenoviruses for cancer gene therapy","volume":"2","author":"Hemminki","year":"2010","journal-title":"Viruses"},{"key":"6","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Koel","year":"2003","journal-title":"Journal of virology"},{"key":"7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"van Rooijen","year":"2008","journal-title":"Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"Wickham","year":"1998","journal-title":"Journal of virology"},{"key":"9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.2002.1359","article-title":"Human adenoviruses of subgenera B, C, and E with various tropisms differ in both binding to and replication in the epithelial A549 and 293 cells","volume":"295","author":"Wadell","year":"2002","journal-title":"Virology"},{"key":"10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/156652307781369137","article-title":"Adenovirus vectors composed of subgroup B adenoviruses","volume":"7","author":"Mizuguchi","year":"2007","journal-title":"Current gene therapy"},{"key":"11","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses CD46 as a cellular receptor","volume":"77","author":"Arnberg","year":"2003","journal-title":"Journal of virology"},{"key":"12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Lieber","year":"2003","journal-title":"Nature medicine"},{"key":"13","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1128\/JVI.78.9.4454-4462.2004","article-title":"The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3","volume":"78","author":"Hemmi","year":"2004","journal-title":"Journal of virology"},{"key":"14","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1128\/JVI.00514-11","article-title":"Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions","volume":"85","author":"Lieber","year":"2011","journal-title":"Journal of virology"},{"key":"15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Lieber","year":"2011","journal-title":"Nature medicine"},{"key":"16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster","volume":"9","author":"Atkinson","year":"1991","journal-title":"Annual review of immunology"},{"key":"17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.it.2004.07.004","article-title":"CD46: expanding beyond complement regulation","volume":"25","author":"Atkinson","year":"2004","journal-title":"Trends in immunology"},{"key":"18","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/JVI.78.9.4385-4388.2004","article-title":"Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet","volume":"78","author":"Cattaneo","year":"2004","journal-title":"Journal of virology"},{"key":"19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2011.03.021","article-title":"Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma","volume":"307","author":"Chen","year":"2011","journal-title":"Cancer letters"},{"key":"20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Keeney","year":"2015","journal-title":"Cancer research"},{"key":"21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00262-004-0590-0","article-title":"Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?","volume":"54","author":"Spendlove","year":"2005","journal-title":"Cancer immunology, immunotherapy : CII"},{"key":"22","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V98.5.1352","article-title":"Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma","volume":"98","author":"Levy","year":"2001","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/8647","article-title":"A system for the propagation of adenoviral vectors with genetically modified receptor specificities","volume":"17","author":"Curiel","year":"1999","journal-title":"Nature biotechnology"},{"key":"24","first-page":"1262","article-title":"Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication","volume":"63","author":"Blackwell","year":"2003","journal-title":"Cancer research"},{"key":"25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1525-0016(03)00243-0","article-title":"Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector","volume":"8","author":"Hayakawa","year":"2003","journal-title":"Molecular therapy"},{"key":"26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0042-6822(03)00161-2","article-title":"Development of adenovirus serotype 35 as a gene transfer vector","volume":"311","author":"Connelly","year":"2003","journal-title":"Virology"},{"key":"27","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s10495-015-1171-8","article-title":"Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma","volume":"20","author":"Tagawa","year":"2015","journal-title":"Apoptosis : an international journal on programmed cell death"},{"key":"28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/gt.2013.44","article-title":"Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction","volume":"20","author":"Baker","year":"2013","journal-title":"Gene therapy"},{"key":"29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/cgt.2011.74","article-title":"Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells","volume":"19","author":"Mizuguchi","year":"2012","journal-title":"Cancer gene therapy"},{"key":"30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/PAI.0b013e31821a0be9","article-title":"CD46 Expression is an unfavorable prognostic factor in breast cancer cases","volume":"19","author":"Surowiak","year":"2011","journal-title":"Applied immunohistochemistry & molecular morphology"},{"key":"31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.5858\/arpa.2013-0064-OA","article-title":"Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer","volume":"138","author":"Nie","year":"2014","journal-title":"Archives of pathology & laboratory medicine"},{"key":"32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/neuonc\/noq057","article-title":"Treatment of medulloblastoma with a modified measles virus","volume":"12","author":"Raffel","year":"2010","journal-title":"Neuro-oncology"},{"key":"33","doi-asserted-by":"crossref","first-page":"e17532","DOI":"10.1371\/journal.pone.0017532","article-title":"Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells","volume":"6","author":"Mei","year":"2011","journal-title":"PloS one"},{"key":"34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/mt.2011.242","article-title":"Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11","volume":"20","author":"Wang","year":"2012","journal-title":"Molecular therapy"},{"key":"35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/JVI.06181-11","article-title":"Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection","volume":"86","author":"Hemmi","year":"2012","journal-title":"Journal of virology"},{"key":"36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.febslet.2013.01.019","article-title":"Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46","volume":"587","author":"Zhang","year":"2013","journal-title":"FEBS letters"},{"key":"37","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.febslet.2012.01.039","article-title":"HBXIP upregulates CD46, CD55 and CD59 through ERK1\/2\/NF-kappaB signaling to protect breast cancer cells from complement attack","volume":"586","author":"Ye","year":"2012","journal-title":"FEBS letters"},{"key":"38","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1089\/hum.1998.9.16-2363","article-title":"The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures","volume":"9","author":"Dummer","year":"1998","journal-title":"Human gene therapy"},{"key":"39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2013.08.032","article-title":"Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapy","volume":"447","author":"Morrison","year":"2013","journal-title":"Virology"},{"key":"40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2009.08.038","article-title":"Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents","volume":"394","author":"Barry","year":"2009","journal-title":"Virology"},{"key":"41","doi-asserted-by":"crossref","first-page":"12109","DOI":"10.1128\/JVI.01370-06","article-title":"A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells","volume":"80","author":"Lieber","year":"2006","journal-title":"Journal of virology"},{"key":"42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1476-4598-9-124","article-title":"HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling","volume":"9","author":"Jung","year":"2010","journal-title":"Molecular cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1158\/0008-5472.CAN-04-3666","article-title":"Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer","volume":"65","author":"Kao","year":"2005","journal-title":"Cancer research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:05:26Z","timestamp":1589288726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":43,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2016,6,21]]}},"alternative-id":["9427","27203670"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9427","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}